These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 269416)

  • 1. Conformational requirements for dopamine-induced vasodilation.
    Volkman PH; Kohli JD; Goldberg LI; Cannon JG; Lee T
    Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3602-6. PubMed ID: 269416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the cardiovascular actions of dopamine and epinine in the dog.
    Itoh H; Kohli JD; Rajfer SI; Goldberg LI
    J Pharmacol Exp Ther; 1985 Apr; 233(1):87-93. PubMed ID: 2858584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ring fluorination on the cardiovascular actions of dopamine and norepinephrine in the dog.
    Goldberg LI; Kohli JD; Cantacuzene D; Kirk KL; Creveling CR
    J Pharmacol Exp Ther; 1980 Jun; 213(3):509-13. PubMed ID: 6894165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consistent unmasking of dopamine-induced dilation of the canine femoral vascular bed.
    Listinsky JJ; Kohli JD; Goldberg LI
    J Pharmacol Exp Ther; 1980 Dec; 215(3):662-7. PubMed ID: 6108364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine vascular actions of N-substituted derivatives of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN).
    Kohli JD; Goldberg LI; Nichols DE
    Eur J Pharmacol; 1979 Jun; 56(1-2):39-44. PubMed ID: 467513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of cardiovascular actions of 2-amino-5,6-dihydroxytetralin by N,N-di-n-propyl substitution.
    Kohli JD; Goldberg LI; McDermed JD
    Eur J Pharmacol; 1982 Jul; 81(2):293-9. PubMed ID: 6126371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N,N-Di-n-propyl dopamine: a qualitatively different dopamine vascular agonist.
    Kohli JD; Goldberg LI; Volkman PH; Cannon JG
    J Pharmacol Exp Ther; 1978 Oct; 207(1):16-22. PubMed ID: 702336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine-like renal and mesenteric vasodilation caused by apomorphine 6-propylnorapomorphine and 2-amino-6, 7-dihydroxy-1,2,3,4-tetrahydronaphthalene.
    Crumly HJ; Pinder RM; Hinshaw WB; Goldberg LI
    Nature; 1976 Feb; 259(5544):584-7. PubMed ID: 1250405
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine induced relaxation of isolated canine renal, mesenteric, and femoral arteries contracted with prostaglandin F2-alpha.
    Goldberg LI; Toda N
    Circ Res; 1975 Jun; 36(6 Suppl 1):97-102. PubMed ID: 236842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
    Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
    J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dopamine receptor agonists and antagonists at peripheral neuronal and vascular dopamine receptors in the anaesthetised dog.
    Hilditch A; Drew GM
    J Cardiovasc Pharmacol; 1984; 6(3):460-9. PubMed ID: 6202973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The actions of dopamine and of sulpiride on regional blood flows in the rat kidney.
    Chapman BJ; Horn NM; Munday KA; Robertson MJ
    J Physiol; 1980 Jan; 298():437-52. PubMed ID: 7359426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the alpha adrenoceptor activity of dopamine, ibopamine and epinine in the pulmonary circulation of the dog.
    Shebuski RJ; Fujita T; Smith JM; Ruffolo RR
    J Pharmacol Exp Ther; 1987 Apr; 241(1):6-12. PubMed ID: 3033210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective DA2 versus DA1 antagonist activity of domperidone in the periphery.
    Kohli JD; Glock D; Goldberg LI
    Eur J Pharmacol; 1983 Apr; 89(1-2):137-41. PubMed ID: 6861882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New dopamine agonists in cardiovascular therapy].
    Girbes AR; Van Veldhuisen DJ; Smit AJ
    Presse Med; 1992 Aug 29-Sep 5; 21(27):1287-91. PubMed ID: 1359528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors.
    Kohli JD; Weder AB; Goldberg LI; Ginos JZ
    J Pharmacol Exp Ther; 1980 May; 213(2):370-4. PubMed ID: 7365696
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of plasma cholinesterase prevents the dopamine DA-1 receptor mediated renal vasodilation produced by ibopamine.
    Nichols AJ; Shebuski RJ; Ruffolo RR
    Eur J Pharmacol; 1987 Sep; 141(3):515-8. PubMed ID: 3666046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-receptor subtypes in the canine coronary circulation.
    Trivella MG; Broten TP; Feigl EO
    Am J Physiol; 1990 Nov; 259(5 Pt 2):H1575-85. PubMed ID: 1978578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ibopamine on diuresis and arterial blood pressure in anesthetized rats and its interactions with dopaminergic and alpha- and beta-adrenergic antagonists.
    Ferrini R; Miragoli G
    Arzneimittelforschung; 1986 Feb; 36(2A):323-6. PubMed ID: 2871844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of effects of dopamine hydrochloride and dopexamine hydrochloride on abdominal and femoral hemodynamics in anesthetized dogs.
    van Kesteren RG; Heethaar RM; Charbon GA; Heethaar J; Brouwer FA
    Circ Shock; 1993 Jul; 40(3):227-33. PubMed ID: 8348685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.